These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21138824)

  • 1. Long-acting β₂ agonists for asthma: a clinical paradox.
    Williams D
    Consult Pharm; 2010 Nov; 25(11):756-9. PubMed ID: 21138824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA's recommendations on the use of long-acting {beta}2 agonists in the management of asthma.
    Robinson CA
    Ann Pharmacother; 2010 Oct; 44(10):1651-4. PubMed ID: 20841520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of serious asthma exacerbations associated with long-acting beta agonists among patients with asthma: a retrospective cohort study.
    Guo JJ; Tsai K; Kelton CM; Bian B; Wigle PR
    Ann Allergy Asthma Immunol; 2011 Mar; 106(3):214-22. PubMed ID: 21354023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists.
    McMahon AW; Levenson MS; McEvoy BW; Mosholder AD; Murphy D
    Pediatrics; 2011 Nov; 128(5):e1147-54. PubMed ID: 22025595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LABAs in asthmatic children: highlights and new inside.
    Miraglia del Giudice M; Matera MG; Capristo C; Conte M; Santaniello F; Chinellato I; Leonardi S; Miraglia del Giudice MC; Perrone L
    Pulm Pharmacol Ther; 2013 Oct; 26(5):540-3. PubMed ID: 23583567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of long-acting beta₂-adrenergic agonists utilization in asthma patients.
    Kaplan S; Zhou EH; Iyasu S
    J Asthma; 2012 Dec; 49(10):1079-85. PubMed ID: 23106094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mometasone/Formoterol (dulera) for asthma.
    Med Lett Drugs Ther; 2010 Oct; 52(1349):83-4. PubMed ID: 21045758
    [No Abstract]   [Full Text] [Related]  

  • 8. The FDA and safe use of long-acting beta-agonists in the treatment of asthma.
    Chowdhury BA; Dal Pan G
    N Engl J Med; 2010 Apr; 362(13):1169-71. PubMed ID: 20181964
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA LABA warning: is there anything new here?
    Weiss ST
    Clin Pharmacol Ther; 2010 Jun; 87(6):638-9. PubMed ID: 20485319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing patterns of asthma medication use related to US Food and Drug Administration long-acting β2-agonist regulation from 2005-2011.
    Butler MG; Zhou EH; Zhang F; Wu YT; Wu AC; Levenson MS; Wu P; Seymour S; Toh S; Iyer A; Iyasu S; Baker MA
    J Allergy Clin Immunol; 2016 Mar; 137(3):710-7. PubMed ID: 26725997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice.
    Dissanayake SB
    AAPS J; 2015 May; 17(3):754-7. PubMed ID: 25712726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta2-agonists use during pregnancy and the risk of congenital malformations.
    Eltonsy S; Forget A; Blais L
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):937-47. PubMed ID: 21948561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The addition of long-acting beta-agonists to inhaled corticosteroids in asthma.
    Sears MR
    Curr Opin Pulm Med; 2011 Jan; 17(1):23-8. PubMed ID: 21045700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.
    Salpeter SR
    Expert Opin Drug Saf; 2010 May; 9(3):407-19. PubMed ID: 20408768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is new with the beta2-agonists: issues in the management of asthma.
    Kelly HW
    Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Not Available].
    Blondel N
    Rev Med Suisse; 2016 Sep; 12(531):1588. PubMed ID: 28678458
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
    Ortega VE; Peters SP
    Curr Opin Pharmacol; 2010 Jun; 10(3):246-53. PubMed ID: 20452285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting beta2-adrenergic agonist in pediatric and adolescent asthma patients, 2003-2011.
    Zhou EH; Kang EM; Seymour S; Iyasu S
    J Asthma; 2014 Dec; 51(10):1061-7. PubMed ID: 24945885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.